Positron emission tomography, or PET, is a technique of Nuclear Imaging. In full expansion, usually associated with a scanner, it allows the early detection of cancers.
Positron emission tomography (PET) grants today medical teams the ability to carry out accurate diagnoses of patients before a disease has had time to spread, as well as to monitor recoveries from surgical operations. In the field of cancer treatments, PET scans allow oncologists to see how patients cope with radiotherapy or chemotherapy, and help in the identification of any potential tumours. A diagnosis obtained with a PET scan can change the way doctors follow a patient, by stopping inefficient treatments, replacing a planned surgery with radiotherapy, or even changing the nature of an intended surgery or therapy.
Radioactive tracers used are beta-plus radioelements, emitters of positive electrons or positrons. After a short range, positrons vanish emitting two back to back gamma rays. The simultaneous detection of this gamma pair allows to locate the zone of emission that is close to the fixation of the radioactive tracer. With many pairs detected, physicists can draw the map of where the radioactive atoms have been fixed by our cells in order to screen the hot spots.
As opposed to iodine 131 or technetium 99m, which are isotopes commonly used in scintigraphy, positron emitters are either light chemicals abundant in the human body (such as oxygen, carbon, nitrogen etc.) or halogens (fluorine 18 or bromine 76) which can easily be incorporated to other molecules. This means that chemicals which play a key role in the human metabolism can be marked with radioactive elements and thus followed around the body. The way human tissue absorbs glucose, for instance, can be mapped after an injection of fluorodeoxyglose (FDG), a chemical marked with radioactive fluorine 18. The absorption of glucose is an important parameter in monitoring a person's health, as it reveals key information about the way different tissues work - whether in the brain, the muscles of the heart or cancerous tumours.
A molecule as simple as water, once it is marked with oxygen 15, can be used to follow the way blood flows through the brain and thus provide a greater understanding of the way it works. These explorations have helped pave the way for new insights in neurology, psychology, linguistics and the cognitive sciences.
Unfortunately, beta-positive isotopes do not exist in nature and must be created in the laboratory.
The half-lives of these artificial positron emitters are very short: oxygen 15 has a period of two minutes while the amount of fluorine 18 halves in just under two hours. These isotopes must therefore be inserted into the body as soon as possible after they are created, and so many hospitals have a cyclotron (a mini-accelerator) to produce these isotopes and a radiochemical laboratory to extract them.
Of all the molecules marked with positron emitters, FDG is by far the most important. Apart from its remarkable biological properties, its 'comparatively long' half-life means that it can be transported from its production site to numerous hospitals in the area. The most common use of FDG in PET scans performed today is the full-body scan performed in clinical oncology to determine the spread of a cancer.
As of the end of 2002, there were over 530 PET cameras in the United States and 215 in Europe, of which only 11 were in France. A recent program to equip French hospitals with PET scanners has allowed France to make up its deficit since 2003. In 2009, 77 TEP were installed and 28 were in the process to be.
Access to page in french
NEXT : PET : principles
NEXT : PET Scan